Rare diseases
Investigational molecules
Locations
Back to Latvia17 clinical trials in Valmiera, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
LatviaComparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery
LatviaLatviaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
LatviaStudy on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia
LatviaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
LatviaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
LatviaComparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery
LatviaStudy on the Safety and Immune Response of mRNA-1345 and mRNA-1365 for Infants with Acute Lower Respiratory Infection Aged 5 to 24 Months
LatviaStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections
LatviaStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis
LatviaTitle: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis
LatviaThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on atherosclerotic cardiovascular disease and stroke prevention, evaluating new therapeutic approaches for patients with various heart conditions.
Research includes evaluation of novel compounds like asundexian and inclisiran for reducing major cardiovascular events.
Comprehensive studies addressing various bacterial infections, with particular focus on complicated urinary tract infections and pneumonia treatments.
Trials investigating new antibiotic combinations and therapeutic approaches for resistant infections.
Advanced research in cancer treatment, particularly focusing on prostate cancer management and innovative hormone therapy approaches.
Evaluation of darolutamide in combination with other therapies for improved patient outcomes.
Specialized research investigating treatments for Immunoglobulin A Nephropathy, focusing on innovative approaches to kidney disease management.
Clinical evaluation of povetacicept for improving kidney function and reducing disease progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
